TrialJAMA network open2022

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Niharika B Mettu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.